JP2006506435A5 - - Google Patents

Download PDF

Info

Publication number
JP2006506435A5
JP2006506435A5 JP2004553487A JP2004553487A JP2006506435A5 JP 2006506435 A5 JP2006506435 A5 JP 2006506435A5 JP 2004553487 A JP2004553487 A JP 2004553487A JP 2004553487 A JP2004553487 A JP 2004553487A JP 2006506435 A5 JP2006506435 A5 JP 2006506435A5
Authority
JP
Japan
Prior art keywords
albumin
solution
crystals
product according
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2004553487A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006506435A (ja
Filing date
Publication date
Priority claimed from US10/300,233 external-priority patent/US7087719B2/en
Application filed filed Critical
Publication of JP2006506435A publication Critical patent/JP2006506435A/ja
Publication of JP2006506435A5 publication Critical patent/JP2006506435A5/ja
Abandoned legal-status Critical Current

Links

JP2004553487A 2002-11-19 2003-10-28 ヒト血清アルブミンの結晶化の方法 Abandoned JP2006506435A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/300,233 US7087719B2 (en) 2002-11-19 2002-11-19 Method for the crystallization of human serum albumin
PCT/US2003/034205 WO2004046311A2 (en) 2002-11-19 2003-10-28 A method for the crystallization of human serum albumin

Publications (2)

Publication Number Publication Date
JP2006506435A JP2006506435A (ja) 2006-02-23
JP2006506435A5 true JP2006506435A5 (https=) 2006-12-21

Family

ID=32297870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004553487A Abandoned JP2006506435A (ja) 2002-11-19 2003-10-28 ヒト血清アルブミンの結晶化の方法

Country Status (8)

Country Link
US (2) US7087719B2 (https=)
EP (1) EP1562991A4 (https=)
JP (1) JP2006506435A (https=)
CN (2) CN1732185A (https=)
AU (1) AU2003285055A1 (https=)
CA (1) CA2506594A1 (https=)
NZ (1) NZ540149A (https=)
WO (1) WO2004046311A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050181482A1 (en) * 2004-02-12 2005-08-18 Meade Harry M. Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
DE69933216T2 (de) * 1998-06-15 2007-09-20 GTC Biotherapeutics, Inc., Framingham Erythropoietin-analog-menschliches serum-albumin fusionsprotein
US7087719B2 (en) * 2002-11-19 2006-08-08 Gtc Biotherapeutics, Inc. Method for the crystallization of human serum albumin
WO2006068548A1 (en) * 2004-12-21 2006-06-29 Telefonaktiebolaget L M Ericsson (Publ) An arrangement and a method relating to flow of packets in communication systems
ES2811526T3 (es) 2010-12-30 2021-03-12 Lab Francais Du Fractionnement Glicoles como agentes de inactivación de patógenos
CN102492027A (zh) * 2011-12-09 2012-06-13 福建省农业科学院农业生物资源研究所 一种提取Bt杀虫蛋白晶体的方法
BR112014027994A2 (pt) * 2012-05-11 2017-06-27 Novartis Ag métodos de cristalização para purificação de anticorpos monoclonais
CN103012581B (zh) * 2012-11-28 2015-11-25 李英俊 制备白蛋白的方法
US10034921B2 (en) 2013-02-13 2018-07-31 Laboratoire Français Du Fractionnement Et Des Biotechnologies Proteins with modified glycosylation and methods of production thereof
EP3594230A1 (en) 2013-02-13 2020-01-15 Laboratoire Français du Fractionnement et des Biotechnologies Highly galactosylated anti-tnf-alpha antibodies and uses thereof
EP3016729B1 (fr) 2013-07-05 2020-03-25 Laboratoire Francais du Fractionnement et des Biotechnologies Societe Anonyme Matrice de chromatographie d'affinité
CN104758924A (zh) * 2014-01-06 2015-07-08 河南省医药科学研究院 包含白蛋白的药物组合物及其用途
GB201409451D0 (en) 2014-05-28 2014-07-09 Ipabc Ltd Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
CN105582883B (zh) * 2015-12-25 2017-12-15 北海开元生物科技有限公司 一种活化硅藻土及在血液制品生产中的应用
WO2019240255A1 (ja) * 2018-06-15 2019-12-19 扶桑薬品工業株式会社 生殖補助医療用培地

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4833233A (en) 1987-08-20 1989-05-23 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Human serum albumin crystals and method of preparation
SE9101149D0 (sv) * 1991-04-17 1991-04-17 Pharmacia Lkb Biotech Beads for down stream processing
US5585466A (en) 1994-12-06 1996-12-17 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Crystals of serum albumin for use in genetic engineering and rational drug design
JP2004536081A (ja) 2001-06-13 2004-12-02 トーラス エイチエスエイ エルエルシー ヒト血清アルブミンの精製
US7087719B2 (en) * 2002-11-19 2006-08-08 Gtc Biotherapeutics, Inc. Method for the crystallization of human serum albumin

Similar Documents

Publication Publication Date Title
JP2006506435A5 (https=)
FR2920429A1 (fr) Procede de purification du facteur viii et du facteur von willebrand
CN103394076A (zh) 一种人血白蛋白的制备工艺
US7087719B2 (en) Method for the crystallization of human serum albumin
JP5908496B2 (ja) トランスジェニックイネの子実からヒト血清アルブミンを抽出する方法
JPH01216939A (ja) 末熟児頭蓋内出血阻止剤
JP3617091B2 (ja) 塩基性アミノ酸の精製方法
JPS6330318B2 (https=)
CN101787027A (zh) 高纯度cbz-伐昔洛韦的制备方法
Hunter et al. The specificity of arginase: action upon argininic acid
PT101006B (pt) Processo de preparacao de (s)(+)-4,4-(1-metil-1,2-etanodiil)-bis-(2,6-piperazinadiona) e uso como medicamento.
JPH03504320A (ja) スブチリシンの結晶化法
EP0470086B1 (en) Process for the purification of hemin, a novel hemin derivative and a process for its preparation
JP2020040894A (ja) プレガバリンの精製方法
JP2007238596A (ja) アミノ酸の二塩酸塩の生成のための直接的なプロセス
JPS5829294B2 (ja) ロイシンおよびイソロイシンの混合物からイソロイシンを精製する方法
RU2067300C1 (ru) Способ очистки инсулина
SU436085A1 (ru) Способ очистки l-аспарагиназы
JPS58140093A (ja) α―インターフエロンの製法
JP3737252B2 (ja) 上皮細胞増殖因子活性を有するタンパク質の回収精製法
CA3205833A1 (en) Crystallisation of beta-lactoglobulin using multiple protein feeds
JPS6366821B2 (https=)
CN119300842A (zh) 通过超滤从血浆制备科恩池浓缩物的方法
SU619188A1 (ru) Способ получени препарата гонадотропинов из сыворотки жеребых кобыл "оваритропина"
CN101959880B (zh) 一种依普罗沙坦甲磺酸盐的制备方法